2000 Central Avenue
Suite 100
Boulder, CO 80301
United States
720 505 4755
https://ir.frtx.com
版塊: Healthcare
行業: Biotechnology
全職員工: 4
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Mr. Albert Nicholas Marchio II | CEO, CFO, Secretary & Chairman | 251.83k | 無 | 1952 |
Aron Aizenstat M.B.A., P.M.P. | Vice President of Corporate Development & Operations | 無 | 無 | 無 |
Mr. Aaron Fox-Collis CPA | VP of Finance & Chief Accounting Officer | 無 | 無 | 無 |
Ms. Sue Fattor | Head of Human Resource | 無 | 無 | 無 |
Dr. James S. McElvain Ph.D. | Interim Head of CMC Development | 無 | 無 | 無 |
Fresh Tracks Therapeutics, Inc. does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.
截至 無 止,Fresh Tracks Therapeutics, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。